Neurofibromatosis type I : mutation spectrum of NF1 in spanish patients
© 2018 John Wiley & Sons Ltd/University College London..
Neurofibromatosis type I (NF1) is one of the most common genetic disorders in humans. NF1, a tumor predisposition syndrome, is caused by heterozygous pathogenic variants in the NF1 gene. Molecular genetic testing of NF1 is complex, especially because of the presence of a high number of partial pseudogenes, some of them with a high percentage of sequence identity. In this study, we have analyzed the largest cohort of NF1 Spanish patients (150 unrelated individuals suspected of having NF1 and 53 relatives, making a total of 203 individuals). Mutation analysis of the entire coding region was performed in all unrelated index patients. Additionally, the Multiplex Ligation-dependent Probe Amplification (MLPA) test of the NF1 gene and SPRED1 gene analysis (sequencing and MLPA test) was performed in some of the negative patients for NF1 point mutations. When fulfilling the National Institutes of Health (NIH) criterion for the clinical diagnosis of NF1, the detection rate was 79%. Among the 80 genetically confirmed NF1 probands, we detected 69 different pathogenic variants. Two mutations (3%) were gross deletions of the whole gene, the remaining 78 mutations (97%) were small changes spread among all NF1 exons. Among these 69 different mutations detected, 42 mutations were described elsewhere, and 27 mutations were novel mutations. When segregation was studied, 67% of mutations resulted de novo variants. No genetic mosaicism was detected on patients' parents.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:82 |
|---|---|
| Enthalten in: |
Annals of human genetics - 82(2018), 6 vom: 15. Nov., Seite 425-436 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Palma Milla, Carmen [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Journal Article |
|---|
| Anmerkungen: |
Date Completed 18.07.2019 Date Revised 18.07.2019 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/ahg.12272 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM286553392 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM286553392 | ||
| 003 | DE-627 | ||
| 005 | 20231225052005.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/ahg.12272 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0955.xml |
| 035 | |a (DE-627)NLM286553392 | ||
| 035 | |a (NLM)30014477 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Palma Milla, Carmen |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Neurofibromatosis type I |b mutation spectrum of NF1 in spanish patients |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.07.2019 | ||
| 500 | |a Date Revised 18.07.2019 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2018 John Wiley & Sons Ltd/University College London. | ||
| 520 | |a Neurofibromatosis type I (NF1) is one of the most common genetic disorders in humans. NF1, a tumor predisposition syndrome, is caused by heterozygous pathogenic variants in the NF1 gene. Molecular genetic testing of NF1 is complex, especially because of the presence of a high number of partial pseudogenes, some of them with a high percentage of sequence identity. In this study, we have analyzed the largest cohort of NF1 Spanish patients (150 unrelated individuals suspected of having NF1 and 53 relatives, making a total of 203 individuals). Mutation analysis of the entire coding region was performed in all unrelated index patients. Additionally, the Multiplex Ligation-dependent Probe Amplification (MLPA) test of the NF1 gene and SPRED1 gene analysis (sequencing and MLPA test) was performed in some of the negative patients for NF1 point mutations. When fulfilling the National Institutes of Health (NIH) criterion for the clinical diagnosis of NF1, the detection rate was 79%. Among the 80 genetically confirmed NF1 probands, we detected 69 different pathogenic variants. Two mutations (3%) were gross deletions of the whole gene, the remaining 78 mutations (97%) were small changes spread among all NF1 exons. Among these 69 different mutations detected, 42 mutations were described elsewhere, and 27 mutations were novel mutations. When segregation was studied, 67% of mutations resulted de novo variants. No genetic mosaicism was detected on patients' parents | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a NF1 | |
| 650 | 4 | |a Neurofibromatosis type 1 | |
| 650 | 4 | |a Spanish patients | |
| 650 | 4 | |a novel mutations | |
| 650 | 7 | |a NF1 protein, human |2 NLM | |
| 650 | 7 | |a Neurofibromin 1 |2 NLM | |
| 700 | 1 | |a Lezana Rosales, José Miguel |e verfasserin |4 aut | |
| 700 | 1 | |a López Montiel, Javier |e verfasserin |4 aut | |
| 700 | 1 | |a Andrés Garrido, Lucas David |e verfasserin |4 aut | |
| 700 | 1 | |a Sánchez Linares, Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Carmona Tamajón, Sandra |e verfasserin |4 aut | |
| 700 | 1 | |a Torres Fernández, Carmen |e verfasserin |4 aut | |
| 700 | 1 | |a Sánchez González, Pablo |e verfasserin |4 aut | |
| 700 | 1 | |a Franco Freire, Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Benito López, Carmen |e verfasserin |4 aut | |
| 700 | 1 | |a López Siles, Juan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of human genetics |d 1954 |g 82(2018), 6 vom: 15. Nov., Seite 425-436 |w (DE-627)NLM00006601X |x 1469-1809 |7 nnns |
| 773 | 1 | 8 | |g volume:82 |g year:2018 |g number:6 |g day:15 |g month:11 |g pages:425-436 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/ahg.12272 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 82 |j 2018 |e 6 |b 15 |c 11 |h 425-436 | ||